secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001628280-25-048815
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q3 net loss $110M; re-establishes FY2025 guidance with negative EBITDA outlook
--------------------------------------------------------------------------------

- Q3 2025 revenue $1.44B, down 1% YoY; net loss $110M vs $118M loss in Q3 2024.
- Adjusted EBITDA loss $91M; medical margin negative $57M; gross profit negative $68M.
- Total members 618,000 (503k MA, 115k ACO), down 6% YoY due to market exits.
- Full-year 2025 guidance: revenue $5.81B-$5.83B; adjusted EBITDA loss ($270M)-($245M).
- Expects $30M operating cost reductions in 2026; risk adjustment revenue shortfall of $73M in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/0001628280-25-048815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025048815/agl-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-048815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer